- A simple test analysing urine and vaginal fluid cells could help rule out womb cancer in women with postmenopausal bleeding.
- Researchers said the approach has the potential to “transform care” for thousands of women annually, and could spare patients from “invasive, uncomfortable” tests.
- A study of 1,864 women showed the combined test of urine and vaginal cell samples correctly identified 80 per cent of cancers and had a 98.8 per cent negative predictive value for womb cancer .
- The test detected 95.8 per cent of high-grade, aggressive tumours and picked up 100 per cent of cancers in black women.
- Professor Emma Davidson, of the University of Manchester and honorary consultant in gynaecological oncology at MFT, said: “If further studies confirm these findings in routine practice, this approach has the potential to transform care for thousands of women every year.”
IN FULL
New simple urine and fluid test could transform womb cancer diagnosis
